The Multicenter Trial SAKK 37/95 of Cladribine, Cyclophosphamide and Prednisone in the Treatment of Chronic Lymphocytic Leukemias and Low-Grade Non-Hodgkin’s Lymphomas

F Laurencet,P. Ballabeni,B Rufener,U. Hess,Thomas Cerny,M. Fey,Jm Luthi,C Plancherel,Gb Zulian

The Multicenter Trial SAKK 37/95 of Cladribine, Cyclophosphamide and Prednisone in the Treatment of Chronic Lymphocytic Leukemias and Low-Grade Non-Hodgkin’s Lymphomas

2007

F Laurencet
P. Ballabeni
B Rufener
U. Hess
Thomas Cerny
M. Fey
Jm Luthi
C Plancherel
Gb Zulian

A multicenter trial was performed to confirm the therapeutic efficacy and the toxicity profile of the combination of cladribine, cyclophosphamide and prednisone in low-grade non-Hodgkin’s lymphoma (NH

Keywords:

Oncology
Lymphoma
Immunology
Medicine
Chronic lymphocytic leukemia
Multicenter trial
Cladribine
Prednisone
Leukemia
Cyclophosphamide
Toxicity
Internal medicine
hodgkin s
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations